Delcath Systems Inc. (NASDAQ:DCTH) saw its shares rise 2.2% in premarket trading Thursday after new research underscored the potential survival benefits of its liver-targeted treatment for metastatic ...

Lancet Liver Commission, published in December, 2021, highlighted that liver disease was the second leading cause of years-of-working-life-lost in Europe (after ischaemic heart disease). The ...

QUEENSBURY, N.Y.--(BUSINESS WIRE)--Delcath Systems, Inc. (NASDAQ: DCTH), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, today announced that the U ...

QUEENSBURY, N.Y.--(BUSINESS WIRE)--Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on liver-directed cancer therapies, today announced that its proprietary CHEMOSAT ® ...

Margot got the news in her early 20s: "You have liver cancer," her doctors told her. Specifically, Margot had a form of liver cancer known as fibrolamellar carcinoma, a diagnosis with deadly prospects ...

Many liver diseases share a common characteristic: fibrosis, that is, the progressive accumulation of scarring in the liver ...

A chemical found in water, NDMA, may cause more cancer in children than in adults, according to a study warning of early-life ...

Cancer of the liver, seen in a radial cross-section abdominal scan. (Photo by: BSIP/Universal Images Group via Getty Images) The number of new liver cancer cases will nearly double in the next 25 ...

In a recent study published in Nature, researchers from Washington University investigated how dietary fructose indirectly promotes tumor growth through metabolic mechanisms involving the liver. The ...